Benitec Biopharma BNTC
NASDAQ BNTC
$9.47 +0.19 (+2.05%)
At close: Nov 11, 2026 · 4:00 PM EST

Benitec Biopharma (BNTC) Net Income Attributable to Noncontrolling Interests (2019 - 2023)

Updated

Analysis

Benitec Biopharma (BNTC) Net Income Attributable to Noncontrolling Interests (2019 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCI Net Income (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 2.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 2.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -1.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 10.00 Mn
10 Benitec Biopharma 432.06 Mn -216.04 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 50,000.00
Dec 31, 2022 -160,000.00
Sep 30, 2022 507,000.00
Dec 31, 2021 -57,000.00
Sep 30, 2021 239,000.00
Dec 31, 2020 208,000.00
Sep 30, 2020 178,000.00
Dec 31, 2019 336,000.00
API Access

Benitec Biopharma Net Income Attributable to Noncontrolling Interests API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=BNTC&period=max&api_key=YOUR_API_KEY